CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Omija extract. +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01472822
NCT01472822Phase 3Completed
CompareCT.gov

Efficacy and Safety of Omija Extract on Gonarthritis

Chonbuk National University Hospital·interventional·Posted Nov 17, 2011·Updated Feb 4, 2013

In Brief

A Phase 3 clinical trial evaluating Omija extract. and Placebo for Mild Knee Osteoarthritis. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Knee osteoarthritis (KO) is a common arthropathy and a leading cause of disability in elderly adults. Schizandra chinensis(Omija) has been known to have five predominant tastes: salty, sweet, sour, astringent, and bitter. It has also been shown to have various effects on the anti-inflammatory, cardiovascular system, gastrointestinal system, central nervous system, endocrine system, and stress protect. Therefore, this study is designed to evaluate the efficacy and safety on KO of Omija extract.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMild Knee Osteoarthritis
CountriesSouth Korea
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 17, 2011
Enrollment StartMar 1, 2011
Primary CompletionJun 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.6 years ago

Interventions

Omija extract.dietary

Omija extract 1.2g/day for 12weeks

Placebodietary

Placebo 1.2g/day for 12weeks